265 related articles for article (PubMed ID: 6152584)
1. [The auricular tissue specialized for conduction: its importance in physiology and antiarrhythmic pharmacotherapy].
Pastelin G; Cuevas B; Alvarado JL; Méndez R
Gac Med Mex; 1984; 120(11-12):371-85. PubMed ID: 6152584
[No Abstract] [Full Text] [Related]
2. [Mechanism of action of antiarrhythmic agents].
Méndez R
Arch Inst Cardiol Mex; 1977; 47(2):223-32. PubMed ID: 901057
[No Abstract] [Full Text] [Related]
3. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.
Baum T; Rowles G; Shropshire AT
J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546
[No Abstract] [Full Text] [Related]
4. Is there a need for new antiarrhythmic drugs?
Roden DM
Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():13-8. PubMed ID: 8734158
[TBL] [Abstract][Full Text] [Related]
5. The pharmacology of Norpace.
Dean RR
Angiology; 1975 Jan; 26(1 Pt 2):67-84. PubMed ID: 1115403
[No Abstract] [Full Text] [Related]
6. The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model.
Rossman EI; Liu K; Morgan GA; Swillo RE; Krueger JA; Gardell SJ; Butera J; Gruver M; Kantrowitz J; Feldman HS; Petersen JS; Haugan K; Hennan JK
J Pharmacol Exp Ther; 2009 Jun; 329(3):1127-33. PubMed ID: 19252062
[TBL] [Abstract][Full Text] [Related]
7. [Comparative studies on heart-lung-preparation of dog. Effect of various antiarrhythmic active substances on the contractility, rate of conductivity, refractory phase and excitability of heart].
Igarashi T; Shyoji T
Arzneimittelforschung; 1968 Nov; 18(11):1368-72. PubMed ID: 5755899
[No Abstract] [Full Text] [Related]
8. Arrhythmias and antiarrhythmic agents.
Heddle WF; Tonkin AM
Med J Aust; 1984 Nov; 141(11):715-8. PubMed ID: 6503764
[No Abstract] [Full Text] [Related]
9. Effect of several new antiarrhythmic agents on atrial contractility.
Covino BG; Shannon CM
Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):185-92. PubMed ID: 5353470
[No Abstract] [Full Text] [Related]
10. The electrophysiology of Norpace (Part II).
Befeler B
Angiology; 1975 Jan; 26(1 Pt 2):116-9. PubMed ID: 1115398
[No Abstract] [Full Text] [Related]
11. [Pharmacological study of (naphtyloxy-1)4-hydroxy-3 butyramidoxime chlorhydrate or LL 1530. Anti-arrhythmic action].
Duteil J; Nadaud J; Henry M; Assous E; Gombert R
Therapie; 1973; 28(4):703-20. PubMed ID: 4793689
[No Abstract] [Full Text] [Related]
12. Mechanisms of action of antiarrhythmic drugs.
Rosen MR; Hoffman BF
Circ Res; 1973 Jan; 32(1):1-8. PubMed ID: 4567446
[No Abstract] [Full Text] [Related]
13. [Experimental anti-arrhythmic action of perhexiline].
Sánchez-Pérez S; Pastelín G; Valenzuela F; Méndez R
Arch Inst Cardiol Mex; 1976; 46(6):696-706. PubMed ID: 799493
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy of cardiac arrhythmias--basic science for clinicians.
Shu J; Zhou J; Patel C; Yan GX
Pacing Clin Electrophysiol; 2009 Nov; 32(11):1454-65. PubMed ID: 19744278
[TBL] [Abstract][Full Text] [Related]
15. Clinical applications of antiarrhythmic drugs.
Lavenne F; de Jonghe D
Acta Cardiol Suppl; 1980; (25):27-42. PubMed ID: 6155012
[No Abstract] [Full Text] [Related]
16. [Cardiac arrhythmias (IV). Auricular flutter: its mapping and radiofrequency ablation].
Arribas F; López Gil M; Goicolea A; García-Cosío F
Rev Esp Cardiol; 1993 Apr; 46(4):246-54. PubMed ID: 8469810
[No Abstract] [Full Text] [Related]
17. Clinical pharmacology of antiarrhythmic drugs: a review and overview, part I.
Singh BN; Cho YW; Kuemmerle HP
Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):139-51. PubMed ID: 7263102
[No Abstract] [Full Text] [Related]
18. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
19. [The effect of naloxone on rhythm disorders and on the conduction system of the heart].
Shliakhto EV; Zaĭtsev AA; Panov AV; Ardashev AV; Nifontov EM; Kashina EA; Kazarin VV; Ivanov VV
Eksp Klin Farmakol; 1996; 59(3):34-6. PubMed ID: 8974581
[TBL] [Abstract][Full Text] [Related]
20. Antiarrhythmic drug therapy.
Stanford JL; Felner JM; Arensberg D
Am J Nurs; 1980 Jul; 80(7):1288-95. PubMed ID: 6901576
[No Abstract] [Full Text] [Related]
[Next] [New Search]
